Table 2.
Group assignment of the patients undergoing liver transplantation for hepatocellular carcinoma in our study.
| Assessment of | Tumour area | TACE | Positive/presence | Negative/absence |
|---|---|---|---|---|
| Ang-2 | TIF | Without | ANG2+ n=25 | ANG2− n=8 |
| Ang-2 | TIF | With | ANG2+ n=38 | ANG2− n=17 |
| Ang-1 | TIF | Without | ANG1+ n=19 | ANG1− n=14 |
| Ang-1 | TIF | With | ANG1+ n=17 | ANG1− n=38 |
| TEMs | TCA | Without | TEM+ n=12 | TEM− n=21 |
| TEMs | TCA | With | TEM+ n=12 | TEM− n=43 |
| CD68+ TAMs | TCA | Without | CD68+ n=12 | CD68− n=21 |
| CD68+ TAMs | TCA | With | CD68+ n=16 | CD68− n=39 |
| M2-polaryzed TAMs | TIF | Without | CD163+ n=28 | CD163− n=5 |
| M2-polaryzaed TAMs | TIF | With | CD163+ n=6 | CD163− n=49 |
Ang-2 – angiopoetin-2; Ang-1 – angiopoetin-1; TAM – tumor associated macrophage; TCA – tumor central area; TEM – Tie2-expressing monocyte; TIF – tumor infiltrating front.